N
Najibeh Shekari
Researcher at Tabriz University of Medical Sciences
Publications - 17
Citations - 211
Najibeh Shekari is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 7, co-authored 14 publications receiving 143 citations. Previous affiliations of Najibeh Shekari include University of Tabriz & Shahid Beheshti University of Medical Sciences and Health Services.
Papers
More filters
Journal ArticleDOI
The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
Mahsa Javadian,Mahsa Javadian,Tohid Gharibi,Najibeh Shekari,Meghdad Abdollahpour-Alitappeh,Ali Mohammadi,Arezoo Hossieni,Hamed Mohammadi,Tohid Kazemi +8 more
TL;DR: This review focuses on important miRNAs capable of targeting MMPs through direct and indirect interactions during the breast cancer development, progression, and metastasis.
Journal ArticleDOI
Parasite-derived microRNAs in plasma as novel promising biomarkers for the early detection of hydatid cyst infection and post-surgery follow-up.
Zahra Alizadeh,Mahmoud Mahami-Oskouei,Adel Spotin,Tohid Kazemi,Ehsan Ahmadpour,Pengfei Cai,Dariush Shanehbandi,Najibeh Shekari +7 more
TL;DR: It seems that these parasite-derived miRNAs, especially egr-miR-71, could serve as novel promising biomarkers for the early diagnosis and monitoring of hydatidosis.
Journal ArticleDOI
Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
TL;DR: Altered expression pattern of circulating miRNAs have correlation with pathological status of GC tissues and their exclusive features make them ideal early diagnostic, prognostic and predictive biomarkers for GC.
Journal ArticleDOI
Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications.
Habib Zarredar,Khalil Ansarin,Behzad Baradaran,Najibeh Shekari,Shirin Eyvazi,Fateme Safari,Safar Farajnia +6 more
TL;DR: Recognizing critical microRNA and controlling the expression of this microRNA by antagonist oligonucleotides like antagomiRs or anti-miRs and microRNA mimicking will have a remarkable role in treating lung cancer.
Journal ArticleDOI
Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer.
Najibeh Shekari,Faezeh Asghari,Navideh Haghnavaz,Dariush Shanehbandi,Vahid Khaze,Behzad Baradaran,Tohid Kazemi +6 more
TL;DR: Alterations in the expression level of let-7a, but not miR-21, and also its target, HMGA2, showed consistent results regarding to the more resistance of KATO III cell line with the highest IC50 concentration.